Brian K. Halak, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 500,000 shares at $20.00 ($10.0M) on 2014-10-21, disclosed to the SEC on 2014-10-21.
Open-market purchase of $10.0M ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |